Sagimet Biosciences Inc. (SGMT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -8.61M | -11.83M | -10.18M | -9.1M | -14.54M | -11.02M | -19.57M | -5.63M | -6.21M | -7.08M | -3.88M | -5.72M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | -193.95% | - |
| Operating CF Growth % | 40.76% | -7.34% | 47.98% | -61.54% | -134.15% | -55.64% | -404.49% | 1.5% | 12.37% | 4.96% | - | - |
| Net Income | -10.65M | -9.57M | -12.91M | -10.39M | -18.18M | -16.2M | -14.62M | -8.12M | -6.63M | -8.15M | -6.35M | -6.79M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 1.69M | 1.69M | 1.6M | 1.47M | 1.53M | 1.55M | 1.45M | 759K | 1.31M | 1.85M | 1.06M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.74M | 337K | 339K | -188K | 2.89M | -19K | -6.29M | -442K | -157K | 37K | 32K | 28K |
| Working Capital Changes | 301K | -4.29M | 701K | -125K | -726K | 3.66M | -205K | 1.48M | -181K | -280K | 587K | -20K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | -569K | 0 | -782K | 0 | 0 | 0 |
| Cash from Investing | 10.22M | 14.36M | 75K | -13.29M | 3.41M | 9.85M | 624K | -75.16M | 3M | -19.62M | 0 | 12.8M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 82.95M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 274K | 1K | 0 | 0 | 0 | -27K | 104.85M | 3.52M | 87.21M | -910K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 274K | 1K | 0 | 0 | 0 | 0 | 105.75M | 3.52M | 86.16M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -27K | -904K | 0 | 1.05M | -910K |
| Net Change in Cash | 1.6M | 2.52M | -9.83M | -22.39M | -11.12M | -1.17M | -18.95M | -80.82M | 101.64M | -26.7M | 83.33M | 6.17M |
| Free Cash Flow | -8.61M | -11.83M | -10.18M | -9.1M | -14.54M | -11.02M | -19.57M | -5.63M | -6.21M | -7.08M | -3.88M | -5.72M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | -193.95% | - |
| FCF Growth % | 40.76% | -7.34% | 47.98% | -61.54% | -134.15% | -55.64% | -404.49% | 1.5% | 12.37% | 4.96% | - | - |
| FCF per Share | -0.26 | -0.37 | -0.31 | -0.28 | -0.45 | -0.34 | -0.61 | -0.18 | -0.21 | -0.39 | -0.21 | -0.26 |
| FCF Conversion (FCF/Net Income) | 0.81x | 1.24x | 0.79x | 0.88x | 0.80x | 0.68x | 1.34x | 0.69x | 0.94x | 0.87x | 0.61x | 0.84x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |